ReP USP - Resultado da busca

Artigo de periodico
Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways (2025)
Salata, Giovanna Cassone ; Malagó, Isabella Draszesski ; Melo, Giovanna Barros de ; Machado Neto, João Agostinho ; Lopes, Luciana Biagini
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: ICB
Assuntos: FARMACOLOGIA, ANTINEOPLÁSICOS, APOPTOSE, NEOPLASIAS MAMÁRIAS, CICLO CELULAR, ENDOCITOSE, NANOPARTÍCULAS, TRANSDUÇÃO DE SINAL CELULAR, MICROTÚBULOS, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALATA, Giovanna Cassone et al. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways. European Journal of Pharmaceutics and Biopharmaceutics, v. 215, 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2025.114837. Acesso em: 27 nov. 2025.
APA
Salata, G. C., Malagó, I. D., Melo, G. B. de, Machado Neto, J. A., & Lopes, L. B. (2025). Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways. European Journal of Pharmaceutics and Biopharmaceutics, 215. doi:10.1016/j.ejpb.2025.114837
NLM
Salata GC, Malagó ID, Melo GB de, Machado Neto JA, Lopes LB. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2025 ; 215[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2025.114837
Vancouver
Salata GC, Malagó ID, Melo GB de, Machado Neto JA, Lopes LB. Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2025 ; 215[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2025.114837
Artigo de periodico
Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: development, characterization and cell-based investigation (2024)
Daré, Regina Gomes ; Costa, Ana Beatriz Chieco; Martins, Tereza Silva ; Lopes, Luciana Biagini
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: ICB
Assuntos: FARMACOLOGIA, ADENOSINA, FERIMENTOS E LESÕES, CITOTOXINAS, ESTATINAS, INIBIDORES DE ENZIMAS, NANOPARTÍCULAS, MEDICAMENTO, EMULSÕES (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARÉ, Regina Gomes et al. Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: development, characterization and cell-based investigation. European Journal of Pharmaceutics and Biopharmaceutics, v. 4, p. 20 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2024.114533. Acesso em: 27 nov. 2025.
APA
Daré, R. G., Costa, A. B. C., Martins, T. S., & Lopes, L. B. (2024). Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: development, characterization and cell-based investigation. European Journal of Pharmaceutics and Biopharmaceutics, 4, 20 . doi:10.1016/j.ejpb.2024.114533
NLM
Daré RG, Costa ABC, Martins TS, Lopes LB. Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: development, characterization and cell-based investigation [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2024 ; 4 20 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2024.114533
Vancouver
Daré RG, Costa ABC, Martins TS, Lopes LB. Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: development, characterization and cell-based investigation [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2024 ; 4 20 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2024.114533
Artigo de periodico
Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis (2022)
Broering, Milena Fronza ; Leão, Matheus de Castro; Rocha, Gustavo Henrique Oliveira da ; Scharf, Pablo Rhasan dos Santos ; Xavier, Luana Filippi; Alves, Aline de Cristo Soares ; Castro, Inar Alves de ; Reutelingsperger, Chris ; Uchiyama, Mayara Klimuk ; Araki, Koiti ; Guterres, Sílvia Stanisçuaski ; Pohlmann, Adriana Raffin ; Farsky, Sandra Helena Poliselli
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: IQ, FCF
Assuntos: CÉLULAS EPITELIAIS, ENTEROPATIAS INFLAMATÓRIAS, MACRÓFAGOS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BROERING, Milena Fronza et al. Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis. European Journal of Pharmaceutics and Biopharmaceutics, v. 181, p. 49-59, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2022.10.022. Acesso em: 27 nov. 2025.
APA
Broering, M. F., Leão, M. de C., Rocha, G. H. O. da, Scharf, P. R. dos S., Xavier, L. F., Alves, A. de C. S., et al. (2022). Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis. European Journal of Pharmaceutics and Biopharmaceutics, 181, 49-59. doi:10.1016/j.ejpb.2022.10.022
NLM
Broering MF, Leão M de C, Rocha GHO da, Scharf PR dos S, Xavier LF, Alves A de CS, Castro IA de, Reutelingsperger C, Uchiyama MK, Araki K, Guterres SS, Pohlmann AR, Farsky SHP. Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2022 ; 181 49-59.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2022.10.022
Vancouver
Broering MF, Leão M de C, Rocha GHO da, Scharf PR dos S, Xavier LF, Alves A de CS, Castro IA de, Reutelingsperger C, Uchiyama MK, Araki K, Guterres SS, Pohlmann AR, Farsky SHP. Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2022 ; 181 49-59.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2022.10.022
Artigo de periodico
Comparing extracellular vesicles and cell membranes as biocompatible coatings for gold nanorods: implications for targeted theranostics (2022)
Lins, Paula Maria Pincela ; Ribovski, Laís ; Antonio, Luana Corsi; Altei, Wanessa Fernanda ; Araújo, Heloísa Sobreiro Selistre; Bernardi, Juliana Cancino; Zucolotto, Valtencir
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: IFSC
Assuntos: FILMES FINOS, POLÍMEROS (MATERIAIS), NANOPARTÍCULAS, OURO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LINS, Paula Maria Pincela et al. Comparing extracellular vesicles and cell membranes as biocompatible coatings for gold nanorods: implications for targeted theranostics. European Journal of Pharmaceutics and Biopharmaceutics, v. 176, p. 168-179, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2022.05.018. Acesso em: 27 nov. 2025.
APA
Lins, P. M. P., Ribovski, L., Antonio, L. C., Altei, W. F., Araújo, H. S. S., Bernardi, J. C., & Zucolotto, V. (2022). Comparing extracellular vesicles and cell membranes as biocompatible coatings for gold nanorods: implications for targeted theranostics. European Journal of Pharmaceutics and Biopharmaceutics, 176, 168-179. doi:10.1016/j.ejpb.2022.05.018
NLM
Lins PMP, Ribovski L, Antonio LC, Altei WF, Araújo HSS, Bernardi JC, Zucolotto V. Comparing extracellular vesicles and cell membranes as biocompatible coatings for gold nanorods: implications for targeted theranostics [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2022 ; 176 168-179.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2022.05.018
Vancouver
Lins PMP, Ribovski L, Antonio LC, Altei WF, Araújo HSS, Bernardi JC, Zucolotto V. Comparing extracellular vesicles and cell membranes as biocompatible coatings for gold nanorods: implications for targeted theranostics [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2022 ; 176 168-179.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2022.05.018
Artigo de periodico
Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression (2021)
Leão, Matheus de Castro; Pohlmann, Adriana Raffin ; Alves, Aline de Cristo Soares; Farsky, Sandra Helena Poliselli ; Uchiyama, Mayara Klimuk ; Araki, Koiti ; Sandri, Silvana; Guterres, Sílvia Stanisçuaski ; Castro, Inar Alves de
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCF, IQ
Assuntos: ARTERIOSCLEROSE, ESTRESSE OXIDATIVO, ÁCIDOS GRAXOS OMEGA 3, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Matheus de Castro et al. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, v. 159, p. 99–107, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2020.12.016. Acesso em: 27 nov. 2025.
APA
Leão, M. de C., Pohlmann, A. R., Alves, A. de C. S., Farsky, S. H. P., Uchiyama, M. K., Araki, K., et al. (2021). Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, 159, 99–107. doi:10.1016/j.ejpb.2020.12.016
NLM
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016
Vancouver
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016
Artigo de periodico
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems (2021)
Luiz, Marcela Tavares; Viegas, Juliana Santos Rosa ; Abriata, Juliana Palma; Viegas, Felipe; Vicentini, Fabiana Testa Moura-de-Carvalho ; Bentley, Maria Vitória Lopes Badra ; Chorilli, Marlus; Marchetti, Juliana Maldonado; Tapia-Blacido, Delia Rita
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCFRP, FFCLRP
Assuntos: NANOTECNOLOGIA, NANOPARTÍCULAS, DESIGNS (CONFIGURAÇÕES COMBINATÓRIAS), SISTEMAS DE DISTRIBUIÇÃO DE MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcela Tavares et al. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2021.05.011. Acesso em: 27 nov. 2025.
APA
Luiz, M. T., Viegas, J. S. R., Abriata, J. P., Viegas, F., Vicentini, F. T. M. -de-C., Bentley, M. V. L. B., et al. (2021). Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, 165, 127-148. doi:10.1016/j.ejpb.2021.05.011
NLM
Luiz MT, Viegas JSR, Abriata JP, Viegas F, Vicentini FTM-de-C, Bentley MVLB, Chorilli M, Marchetti JM, Tapia-Blacido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 165 127-148.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2021.05.011
Vancouver
Luiz MT, Viegas JSR, Abriata JP, Viegas F, Vicentini FTM-de-C, Bentley MVLB, Chorilli M, Marchetti JM, Tapia-Blacido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 165 127-148.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2021.05.011
Artigo de periodico
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers (2021)
Di Filippo, Leonardo Delello; Azambuja, Juliana Hofstäter; Dutra, Jessyca Aparecida Paes; Luiz, Marcela Tavares ; Duarte, Jonatas Lobato; Nicoleti, Luiza Ribeiro; Saad, Sara Teresinha Olalla; Chorilli, Marlus
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCFRP
Assuntos: ANTINEOPLÁSICOS, NEOPLASIAS CEREBRAIS, FARMACOCINÉTICA, FARMACOTERAPIA, SISTEMAS DE DISTRIBUIÇÃO DE MEDICAMENTOS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DI FILIPPO, Leonardo Delello et al. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2021.08.011. Acesso em: 27 nov. 2025.
APA
Di Filippo, L. D., Azambuja, J. H., Dutra, J. A. P., Luiz, M. T., Duarte, J. L., Nicoleti, L. R., et al. (2021). Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics, 168, 76-89. doi:10.1016/j.ejpb.2021.08.011
NLM
Di Filippo LD, Azambuja JH, Dutra JAP, Luiz MT, Duarte JL, Nicoleti LR, Saad STO, Chorilli M. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 168 76-89.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2021.08.011
Vancouver
Di Filippo LD, Azambuja JH, Dutra JAP, Luiz MT, Duarte JL, Nicoleti LR, Saad STO, Chorilli M. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 168 76-89.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2021.08.011
Artigo de periodico
Preclinical and clinical studies to evaluate cutaneous biodistribution, safety and efficacy of UV filters encapsulated in mesoporous silica SBA-15 (2021)
Daneluti, André Luís Máximo; Guerra, Lucas Offenbecker; Velasco, Maria Valéria Robles ; Matos, Jivaldo do Rosário ; Baby, André Rolim ; Kalia, Yogeshvar N
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCF, IQ
Assuntos: FILTRO SOLAR, PELE, TECNOLOGIAS DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANELUTI, André Luís Máximo et al. Preclinical and clinical studies to evaluate cutaneous biodistribution, safety and efficacy of UV filters encapsulated in mesoporous silica SBA-15. European Journal of Pharmaceutics and Biopharmaceutics, v. 169, p. 113–124, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2021.10.002. Acesso em: 27 nov. 2025.
APA
Daneluti, A. L. M., Guerra, L. O., Velasco, M. V. R., Matos, J. do R., Baby, A. R., & Kalia, Y. N. (2021). Preclinical and clinical studies to evaluate cutaneous biodistribution, safety and efficacy of UV filters encapsulated in mesoporous silica SBA-15. European Journal of Pharmaceutics and Biopharmaceutics, 169, 113–124. doi:10.1016/j.ejpb.2021.10.002
NLM
Daneluti ALM, Guerra LO, Velasco MVR, Matos J do R, Baby AR, Kalia YN. Preclinical and clinical studies to evaluate cutaneous biodistribution, safety and efficacy of UV filters encapsulated in mesoporous silica SBA-15 [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 169 113–124.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2021.10.002
Vancouver
Daneluti ALM, Guerra LO, Velasco MVR, Matos J do R, Baby AR, Kalia YN. Preclinical and clinical studies to evaluate cutaneous biodistribution, safety and efficacy of UV filters encapsulated in mesoporous silica SBA-15 [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 169 113–124.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2021.10.002
Artigo de periodico
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities (2019)
Barbosa, Eduardo José ; Löbenberg, Raimar; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Assuntos: MATERIAIS NANOESTRUTURADOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Eduardo José et al. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. European Journal of Pharmaceutics and Biopharmaceutics, v. 141, p. 58-69, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2019.05.004. Acesso em: 27 nov. 2025.
APA
Barbosa, E. J., Löbenberg, R., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2019). Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. European Journal of Pharmaceutics and Biopharmaceutics, 141, 58-69. doi:10.1016/j.ejpb.2019.05.004
NLM
Barbosa EJ, Löbenberg R, Araujo GLB de, Bou-Chacra NA. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 141 58-69.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2019.05.004
Vancouver
Barbosa EJ, Löbenberg R, Araujo GLB de, Bou-Chacra NA. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 141 58-69.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2019.05.004
Artigo de periodico
Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries (2019)
Cazarim, Estael Luzia Coelho da Cruz ; Cazarim, Maurilio de Souza ; Ogunjimi, Abayaomi Tolulope ; Petrilli, Raquel ; Rocha, Eduardo Melani ; Lopez, Renata Fonseca Vianna
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCFRP, FMRP
Assuntos: INSULINA, OFTALMOPATIAS, CÓRNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAZARIM, Estael Luzia Coelho da Cruz et al. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries. European Journal of Pharmaceutics and Biopharmaceutics, v. 140, p. 1-10, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2019.04.014. Acesso em: 27 nov. 2025.
APA
Cazarim, E. L. C. da C., Cazarim, M. de S., Ogunjimi, A. T., Petrilli, R., Rocha, E. M., & Lopez, R. F. V. (2019). Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries. European Journal of Pharmaceutics and Biopharmaceutics, 140, 1-10. doi:10.1016/j.ejpb.2019.04.014
NLM
Cazarim ELC da C, Cazarim M de S, Ogunjimi AT, Petrilli R, Rocha EM, Lopez RFV. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 140 1-10.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2019.04.014
Vancouver
Cazarim ELC da C, Cazarim M de S, Ogunjimi AT, Petrilli R, Rocha EM, Lopez RFV. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 140 1-10.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2019.04.014
Artigo de periodico
Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer (2019)
Silva, Daniela Amaral; Gousous, Jozef Al; Davies, Neal M; Bou-Chacra, Nadia Araci ; Webster, Gregory K; Lipka, Elke; Amidon, Gordon; Löbenberg, Raimar
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Assuntos: FÁRMACOS, FORMAS FARMACÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer. European Journal of Pharmaceutics and Biopharmaceutics, v. 142, p. 8-19, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2019.06.006. Acesso em: 27 nov. 2025.
APA
Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2019). Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer. European Journal of Pharmaceutics and Biopharmaceutics, 142, 8-19. doi:10.1016/j.ejpb.2019.06.006
NLM
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon G, Löbenberg R. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 142 8-19.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2019.06.006
Vancouver
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon G, Löbenberg R. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 142 8-19.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2019.06.006
Artigo de periodico
Influence and effect of osmolytes in biopharmaceutical formulations (2018)
Wlodarczyk, Samarina Rodrigues; Custódio, Débora; Pessoa Junior, Adalberto ; Monteiro, Gisele
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Assuntos: EXCIPIENTES, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WLODARCZYK, Samarina Rodrigues et al. Influence and effect of osmolytes in biopharmaceutical formulations. European Journal of Pharmaceutics and Biopharmaceutics, v. 131, p. 92-98, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2018.07.019. Acesso em: 27 nov. 2025.
APA
Wlodarczyk, S. R., Custódio, D., Pessoa Junior, A., & Monteiro, G. (2018). Influence and effect of osmolytes in biopharmaceutical formulations. European Journal of Pharmaceutics and Biopharmaceutics, 131, 92-98. doi:10.1016/j.ejpb.2018.07.019
NLM
Wlodarczyk SR, Custódio D, Pessoa Junior A, Monteiro G. Influence and effect of osmolytes in biopharmaceutical formulations [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ; 131 92-98.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2018.07.019
Vancouver
Wlodarczyk SR, Custódio D, Pessoa Junior A, Monteiro G. Influence and effect of osmolytes in biopharmaceutical formulations [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ; 131 92-98.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2018.07.019
Artigo de periodico
Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells (2018)
Pedro, Rafael de Oliveira; Hoffmann, Stephan; Pereira, Susana; Goycoolea, Francisco M; Cavalheiro, Carla Cristina Schmitt ; Neumann, Miguel Guillermo
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: IQSC
Assunto: QUITOSANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRO, Rafael de Oliveira et al. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics, v. 131, p. 203-210, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2018.08.009. Acesso em: 27 nov. 2025.
APA
Pedro, R. de O., Hoffmann, S., Pereira, S., Goycoolea, F. M., Cavalheiro, C. C. S., & Neumann, M. G. (2018). Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics, 131, 203-210. doi:10.1016/j.ejpb.2018.08.009
NLM
Pedro R de O, Hoffmann S, Pereira S, Goycoolea FM, Cavalheiro CCS, Neumann MG. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ;131203-210.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2018.08.009
Vancouver
Pedro R de O, Hoffmann S, Pereira S, Goycoolea FM, Cavalheiro CCS, Neumann MG. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ;131203-210.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2018.08.009
Artigo de periodico
Iontophoresis-stimulated silk fibroin films as a peptide delivery system for wound healing (2018)
Lemos, Camila Nunes; Cubayachi, Camila; Dias, Karina; Mendonça, Jacqueline Nakau; Lopes, Norberto Peporine ; Furtado, Niege Araçari Jacometti Cardoso ; Lopez, Renata Fonseca Vianna
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCFRP
Assuntos: AGENTES ANTIMICROBIANOS, BACTÉRIAS, SOBREVIVÊNCIA CELULAR, SISTEMAS DE DISTRIBUIÇÃO DE MEDICAMENTOS, IONTOFORESE, CONTROLE DE INFECÇÕES, NEUROTENSINA, FERIMENTOS E LESÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEMOS, Camila Nunes et al. Iontophoresis-stimulated silk fibroin films as a peptide delivery system for wound healing. European Journal of Pharmaceutics and Biopharmaceutics, v. 128, p. 147-155, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2018.04.019. Acesso em: 27 nov. 2025.
APA
Lemos, C. N., Cubayachi, C., Dias, K., Mendonça, J. N., Lopes, N. P., Furtado, N. A. J. C., & Lopez, R. F. V. (2018). Iontophoresis-stimulated silk fibroin films as a peptide delivery system for wound healing. European Journal of Pharmaceutics and Biopharmaceutics, 128, 147-155. doi:10.1016/j.ejpb.2018.04.019
NLM
Lemos CN, Cubayachi C, Dias K, Mendonça JN, Lopes NP, Furtado NAJC, Lopez RFV. Iontophoresis-stimulated silk fibroin films as a peptide delivery system for wound healing [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ; 128 147-155.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2018.04.019
Vancouver
Lemos CN, Cubayachi C, Dias K, Mendonça JN, Lopes NP, Furtado NAJC, Lopez RFV. Iontophoresis-stimulated silk fibroin films as a peptide delivery system for wound healing [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ; 128 147-155.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2018.04.019
Artigo de periodico
Antioxidant-based topical formulations influence on the inflammatory response of Japanese skin: a clinical study using non-invasive techniques (2017)
Wagemaker, Tais A. L.; Maia-Campos, Patrícia Maria Berardo G; Shimizu, Kenji; Kyotani, Daiki; Yoshida, Daisuke
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCFRP
Assuntos: ANTI-INFLAMATÓRIOS, ANTIOXIDANTES, INTERLEUCINAS, MICROSCOPIA CONFOCAL, PELE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAGEMAKER, Tais A. L. et al. Antioxidant-based topical formulations influence on the inflammatory response of Japanese skin: a clinical study using non-invasive techniques. European Journal of Pharmaceutics and Biopharmaceutics, v. 117, p. 195-202, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.03.025. Acesso em: 27 nov. 2025.
APA
Wagemaker, T. A. L., Maia-Campos, P. M. B. G., Shimizu, K., Kyotani, D., & Yoshida, D. (2017). Antioxidant-based topical formulations influence on the inflammatory response of Japanese skin: a clinical study using non-invasive techniques. European Journal of Pharmaceutics and Biopharmaceutics, 117, 195-202. doi:10.1016/j.ejpb.2017.03.025
NLM
Wagemaker TAL, Maia-Campos PMBG, Shimizu K, Kyotani D, Yoshida D. Antioxidant-based topical formulations influence on the inflammatory response of Japanese skin: a clinical study using non-invasive techniques [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 117 195-202.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2017.03.025
Vancouver
Wagemaker TAL, Maia-Campos PMBG, Shimizu K, Kyotani D, Yoshida D. Antioxidant-based topical formulations influence on the inflammatory response of Japanese skin: a clinical study using non-invasive techniques [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 117 195-202.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2017.03.025
Artigo de periodico
Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics (2017)
Perinelli, Diego Romano; Vllasaliu, Driton; Bonacucina, Giulia; Come, Benedetta; Pucciarelli, Stefania; Ricciutelli, Massimo; Cespi, Marco; Spinozzi, Francesco; Palmieri, Giovanni Filippo; Casettari, Luca; Itri, Rosangela
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: IF
Assuntos: BIOQUÍMICA, BIOFÍSICA, MEMBRANAS (BIOLOGIA), BIOQUÍMICA CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERINELLI, Diego Romano et al. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics. European Journal of Pharmaceutics and Biopharmaceutics, v. 119, p. 419-425, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-06788-7. Acesso em: 27 nov. 2025.
APA
Perinelli, D. R., Vllasaliu, D., Bonacucina, G., Come, B., Pucciarelli, S., Ricciutelli, M., et al. (2017). Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics. European Journal of Pharmaceutics and Biopharmaceutics, 119, 419-425. doi:10.1038/s41598-017-06788-7
NLM
Perinelli DR, Vllasaliu D, Bonacucina G, Come B, Pucciarelli S, Ricciutelli M, Cespi M, Spinozzi F, Palmieri GF, Casettari L, Itri R. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 119 419-425.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-017-06788-7
Vancouver
Perinelli DR, Vllasaliu D, Bonacucina G, Come B, Pucciarelli S, Ricciutelli M, Cespi M, Spinozzi F, Palmieri GF, Casettari L, Itri R. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 119 419-425.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-017-06788-7
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Assuntos: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 27 nov. 2025.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Artigo de periodico
Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy (2017)
Ferreira, Natália N.; Ferreira, Leonardo Mortensen Nunes; Miranda-Gonçalves, Vera; Reis, Rui Manuel ; Seraphim, Thiago Vargas ; Borges, Julio Cesar ; Baltazar, Fátima ; Gremiao, Maria Palmira Daflon
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: IQSC
Assuntos: BIOLOGIA CELULAR, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Natália N. et al. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 119, p. 271-282, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.06.028. Acesso em: 27 nov. 2025.
APA
Ferreira, N. N., Ferreira, L. M. N., Miranda-Gonçalves, V., Reis, R. M., Seraphim, T. V., Borges, J. C., et al. (2017). Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 119, 271-282. doi:10.1016/j.ejpb.2017.06.028
NLM
Ferreira NN, Ferreira LMN, Miranda-Gonçalves V, Reis RM, Seraphim TV, Borges JC, Baltazar F, Gremiao MPD. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 119 271-282.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2017.06.028
Vancouver
Ferreira NN, Ferreira LMN, Miranda-Gonçalves V, Reis RM, Seraphim TV, Borges JC, Baltazar F, Gremiao MPD. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 119 271-282.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2017.06.028
Artigo de periodico
Development of cationic nanocrystals for ocular delivery (2016)
Romero, Gregori Bahu; Keck, Cornelia M; Müller, Rainer H; Bou-Chacra, Nadia Araci
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Assuntos: NANOTECNOLOGIA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMERO, Gregori Bahu et al. Development of cationic nanocrystals for ocular delivery. European Journal of Pharmaceutics and Biopharmaceutics, v. 107, p. 215-222, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2016.07.005. Acesso em: 27 nov. 2025.
APA
Romero, G. B., Keck, C. M., Müller, R. H., & Bou-Chacra, N. A. (2016). Development of cationic nanocrystals for ocular delivery. European Journal of Pharmaceutics and Biopharmaceutics, 107, 215-222. doi:10.1016/j.ejpb.2016.07.005
NLM
Romero GB, Keck CM, Müller RH, Bou-Chacra NA. Development of cationic nanocrystals for ocular delivery [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 107 215-222.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2016.07.005
Vancouver
Romero GB, Keck CM, Müller RH, Bou-Chacra NA. Development of cationic nanocrystals for ocular delivery [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 107 215-222.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2016.07.005
Artigo de periodico
Development and characterization of novel 1-(1-Naphthyl)piperazine-loaded lipid vesicles for prevention of UV-induced skin inflammation (2016)
Menezes, Ana Catarina; Campos, Patrícia Mazureki; Euletério, Carla; Simões, Sandra; Praça, Fabíola Silva Garcia; Bentley, Maria Vitória Lopes Badra; Ascenso, Andreia
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCFRP
Assuntos: FÁRMACOS IMUNOSSUPRESSORES, PELE, INFLAMAÇÃO, NEOPLASIAS CUTÂNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEZES, Ana Catarina et al. Development and characterization of novel 1-(1-Naphthyl)piperazine-loaded lipid vesicles for prevention of UV-induced skin inflammation. European Journal of Pharmaceutics and Biopharmaceutics, v. 104, p. 101-109, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2016.04.023. Acesso em: 27 nov. 2025.
APA
Menezes, A. C., Campos, P. M., Euletério, C., Simões, S., Praça, F. S. G., Bentley, M. V. L. B., & Ascenso, A. (2016). Development and characterization of novel 1-(1-Naphthyl)piperazine-loaded lipid vesicles for prevention of UV-induced skin inflammation. European Journal of Pharmaceutics and Biopharmaceutics, 104, 101-109. doi:10.1016/j.ejpb.2016.04.023
NLM
Menezes AC, Campos PM, Euletério C, Simões S, Praça FSG, Bentley MVLB, Ascenso A. Development and characterization of novel 1-(1-Naphthyl)piperazine-loaded lipid vesicles for prevention of UV-induced skin inflammation [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 104 101-109.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2016.04.023
Vancouver
Menezes AC, Campos PM, Euletério C, Simões S, Praça FSG, Bentley MVLB, Ascenso A. Development and characterization of novel 1-(1-Naphthyl)piperazine-loaded lipid vesicles for prevention of UV-induced skin inflammation [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 104 101-109.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.ejpb.2016.04.023

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos